Areas of oxygen-deficient muscle that often withstand regular treatments are usually present in tumors. Because of the need for air to work in tumors, this is a problem. A novel mechanism of action that does n’t require oxygen has been created by a global research team. Polymeric incorporated nanocatalysts selectively target the tumor cells and turn off the oxygen-requiring antioxidant.
Areas of oxygen-deficient muscle that often withstand regular treatments are usually present in tumors. Because of the need for air to work in tumors, this is a problem. A novel mechanism of action that does n’t require oxygen has been created by a global research team. Polymeric incorporated nanocatalysts selectively target the tumor cells and turn off the oxygen-requiring antioxidant.The group headed by Dr. Johannes Karges from the Faculty of Chemistry and Biochemistry at Ruhr University Bochum, Germany, published their findings in the journal Nature Communications on October 31, 2024.
Why lesions shrink but do n’t vanish
” Tumors often contain areas that are not getting enough oxygen because they grow very quickly, consume a lot of oxygen, and their vascular growth ca n’t necessarily keep up,” explains Johannes Karges. These sections, often in the center of the tumor, usually survive treatment with conventional medicines, so that the tumor first shrinks but does n’t disappear entirely. Because air is necessary for the effectiveness of healing drugs, this is the case.
Without air, the Karges ‘ team’s system of motion functions. It’s a precursor made up of the ingredient metal, which neutralizes the naturally occurring antioxidant in cancer tissues. The availability of antioxidant makes it crucial for cell life and provides protection from a wide range of diverse influences. If it ceases to be effective, the battery worsens.
In lesion cells, substance accumulates.
All tissues of the brain need and have glutathione. The motivator, which is packaged in thermoplastic particles that are exclusively accumulated in tumor cells, has a careful effect on tumor tissues. Research on tumor cell and on animals with human cancers, that were considered chronic, proved effective. Johannes Karges’s statement,” These are stimulating effects that need to be confirmed in future reports,” is unwavering. ” However, there’s a lot of research work to be done before it can be used in people”.
